CASSANDRA FANCHER: Open Payments
NPI 1962248575 · KENNEWICK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 29 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $78 · 2025 $645
Food & beverage: $445Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $261 |
| Incyte Corporation | 2 | $138 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Lilly USA, LLC | 2 | $32 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $20 |
| LEO Pharma Inc. | 1 | $19 |
| GENZYME CORPORATION | 1 | $19 |
| MERZ NORTH AMERICA, INC. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
Products named: TREMFYA, Opzelura, DUPIXENT, Zoryve, SKYRIZI, ANZUPGO, Xeomin, TALTZ.
Industry payments across WA — which companies pay providers there.
